A cost effective strategy of bevacizumab in treatment of primary ovarian cancer — A subset analysis of ICON 7 trial

Journal article

J. Chan, T. Herzog, L. Hu, T. Kiet, Bradley J. Monk, D. Kapp and X. Yu

Gynecologic Oncology, Vol.125, Supplement 1(0), pp.S15-S16

2012

Metrics

4 Record Views

Title: A cost effective strategy of bevacizumab in treatment of primary ovarian cancer — A subset analysis of ICON 7 trial
Creators: J. Chan (Author)
T. Herzog (Author)
L. Hu (Author)
T. Kiet (Author)
Bradley J. Monk (Author) - Creighton University
D. Kapp (Author)
X. Yu (Author)
Publication Details: Gynecologic Oncology, Vol.125, Supplement 1(0), pp.S15-S16
Number of pages: S15-S16
Identifiers: 991005931410602656
Academic Unit: School of Medicine
Resource Type: Journal article